Influenza A H1N1 and anakinra exposure in a patient with gout.
Nocturne
Gaëtane
G
Ora
Jérémy
J
Ea
Hang-Korng
HK
Lioté
Frédéric
F
D000328:Adult; D018501:Antirheumatic Agents / Q000009:adverse effects / Q000627:therapeutic use; D006073:Gout / Q000188:drug therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D053118:Influenza A Virus, H1N1 Subtype; D009980:Influenza A virus; D007251:Influenza, Human / Q000175:diagnosis* / Q000209:etiology; D053590:Interleukin 1 Receptor Antagonist Protein / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D009894:Opportunistic Infections / Q000175:diagnosis / Q000209:etiology
D018501:Antirheumatic Agents; D007166:Immunosuppressive Agents; D053590:Interleukin 1 Receptor Antagonist Protein